 |
Chimeric locked nucleic acid deoxynucleoside phosphorothioate-linked oligonucleotide inhibitor directed against microRNA-155-5p |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2017-05-22 00:00:00 |
| Sponsor | Miragen Therapeutics Europe Ltd |
Related Access Program